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Background: Corneal ulceration leading to perforation is associated with infectious and non-infectious destructive
conditions in the cornea. The fibrinolytic (plasminogen/plasmin) system is considered to contribute to tissue
remodeling in the wound healing process and it is believed to play an important role in proteolysis and fibrosis.
To determine the localization of urokinase-type plasminogen activator (u-PA), u-PA receptor (u-PAR) and
α2-antiplasmin (α2AP) in the tissue of a corneal perforation, we investigated immunohistochemical expressions of
u-PA, u-PAR, α2AP, CD68, and α-smooth muscle actin (α-SMA) in a patient with corneal perforation that developed
from an ulcer of no clear cause.
Case presentation: The patient was a 77-year-old woman who presented with a perforated corneal ulcer in her
right eye. The cause of her corneal ulcer was unknown. Double immunohistochemistry was performed for the
combinations of u-PA with u-PAR, CD68 or α-SMA and α2AP with CD68 or α-SMA to detect the localization of u-PA
and α2AP. u-PA and u-PAR co-localization was seen in the corneal ulceration area. u-PA was mainly observed in
CD68-positive cells and in some α-SMA positive cells. On the other hand, α2AP was not expressed in CD68-positive
cells, but was expressed in α-SMA positive cells.
Conclusion: We identified expression of the u-PA/u-PAR complex and α2AP in a patient with a corneal ulcer. These
two molecules are believed to play a crucial role in inflammatory cell recruitment, ECM synthesis and degradation
during corneal wound healing.
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Inflammatory cells and activated corneal fibroblasts are
main contributors to the wound healing process of cor-
neal ulcers. These cells migrate to the wound edge in re-
sponse to injury, synthesize enzymes that can degrade
the extracellular matrix (ECM) proteins, produce ECM,
and contribute to tissue remodeling [1].* Correspondence: sugioka@med.kindai.ac.jp
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reproduction in any medium, provided the orVarious factors cause prolonged degradation of the ECM,
which sometimes leads to corneal perforation. In these
processes, inflammatory cells such as macrophages and
activated corneal fibroblasts persist in the cornea, causing
an imbalance between tissue degradation and remodeling,
and eventually worsening the pathological condition.
Fibrinolytic enzymes and matrix metalloproteinase are
considered to be crucial factors engaged in the regula-
tion of tissue degradation and remodeling [2,3].
Urokinase-type plasminogen activator (u-PA) is a highly
restricted serine protease that binds to a specific recep-
tor (u-PAR) resulting in enhanced cellular proteolysis vial Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sugioka et al. BMC Ophthalmology 2012, 12:60 Page 2 of 6
http://www.biomedcentral.com/1471-2415/12/60the degradation of matrix components or activation of
plasminogen [4-7], whereas active plasmin is mainly
inhibited by α2-antiplasmin (α2AP) [8,9].
In the current investigation, we observed expressions
of u-PA, u-PAR, CD68, α-smooth muscle actin (α-SMA)
and α2AP using the cornea of a patient with a corneal
perforation.
Case presentation
A 77-year-old woman was referred to the authors in
September 2011 for a corneal perforation in her right
eye. She complained that she had “hot” tears running
out of her eye 2 days before the examination. She exhib-
ited iritis once or twice a year for approximately 15
years. In each episode, she was treated with steroid and
antibiotic eye drops in her right eye for a period between
2 weeks and 1 month. On her first visit to our clinic, the
center of the cornea was perforated and a corneal stro-
mal opacity with fibrosis was seen surrounding the per-
foration area (Figure 1). Diagnosis of corneal perforation
was made by slit-lamp examination in combination with
the Seidel test. The detailed time line of corneal ulcer
development was unknown. She had no history of
rheumatoid arthritis, dry eyes, eye trauma, corneal surgery
or neurotrophic keratopathy. No bacteria or fungi growth
was observed in a specimen from the perforated area.
Penetrating keratoplasty was performed in the right
eye 2 days after the first visit. The cataract was extracted
and an intraocular lens was implanted into the patient’s
right eye. A sample of the central corneal button was
obtained and processed for histological examination.
Our research protocols followed the tenets of the Dec-
laration of Helsinki and the patient gave her informed
consent after an explanation of the possible conse-
quences of the study. This study was approved by the
IRB/Ethics Committee at Kinki University.
Light microscopic histological examination and
immunohistochemistry
The corneal sample was fixed in Super Fix (Kurabo In-
dustries, Osaka, Japan) and embedded in paraffin. ThinFigure 1 Clinical findings in the right eye of a 77-year-old female. The
with fibrosis was seen surrounding the perforation area (B).sections (4 μm) were cut and stained with hematoxylin-
eosin (HE). Immunostaining for u-PA, u-PAR, CD68
(monocyte and macrophage marker), α-SMA (the most
widely observed marker of myofibroblast formation) and
α2AP were performed as follows. Sections were deparaf-
finized and incubated for 20 min at 120°C with Target
Retrieval Solution (x10; DAKO, Glostrup, Denmark).
They were then cooled down for 30 min at room
temperature (RT), washed three times with TNT (0.1 M
Tris–HCl, pH7.5, containing 0.15 M NaCl, 0.05% Tween
20) wash buffer, and incubated for 30 min with a mix-
ture of 200 ml methanol and 1 ml H2O2 at RT. After
washing three times with TNT wash buffer, sections
were exposed to TNB (0.1 M Tris–HCl, pH7.5, contain-
ing 0.15 M NaCl, 0.5% Blocking Reagent [PerkinElmer,
Waltham, MA, USA]) blocking buffer for 1 h at RT, and
were then incubated with goat anti-u-PA antibody (1:200
dilution in TNB; American Diagnostica, Stamford, CT,
USA), rabbit anti-u-PAR antibody (1:200 dilution in
TNB; Abcam, Inc, Cambridge, MA, USA), mouse anti-
CD68 antibody (1:200 dilution in TNB; Abcam, Inc),
rabbit anti- α-SMA antibody (1:200 dilution in TNB;
Abcam, Inc), and goat anti-α2AP antibody (1:200 dilu-
tion in TNB; Abcam, Inc) at 4°C overnight. After wash-
ing three times with TNT wash buffer, sections were
incubated for 30 min at RT with an appropriate second-
ary antibody conjugated with horse-radish peroxidase.
Signals were visualized using a tyramide signal amplifica-
tion system (TSA PLUS; PerkinElmer) according to the
manufacturer’s instructions. Sections were photographed
under fluorescence microscopy (E800; Canon, Tokyo,
Japan) with a CCD camera.Double immunohistochemistry
Double immunohistochemistry was performed for the
combinations of u-PA with u-PAR, CD68, or α-SMA. Goat
anti-u-PA primary antibody was applied and then incu-
bated with anti-goat IgG-HRP, and was revealed using a
tyramide signal amplification system labeled with fluores-
cein isothiocyanate (FITC). Rabbit anti-u-PAR antibody,
mouse anti-CD68 antibody or rabbit anti-α-SMA antibodycenter of the cornea was perforated (A) and corneal stromal opacity
Figure 2 Photomicrograph of corneal tissue near the perforation. A, B: Hematoxylin & eosin staining, original magnification ×40 and ×400.
B: Magnified view of the boxed area in A.
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amplification system labeled Cyanine 3.
For the combinations of α2AP with CD68 or α-SMA,
double immunohistochemical staining was performed.
Goat anti-α2AP antibody was applied and then incu-
bated with anti-goat IgG-HRP and was revealed using a
tyramide signal amplification system labeled with FITC.
Mouse anti-CD68 antibody or rabbit anti-α-SMA anti-
body was then applied accordingly and was revealed by a
tyramide signal amplification system labeled with Cya-
nine 3 (Cy3). Double-stained sections were examined
under a laser scanning confocal microscope (LSM 510
META; Carl Zeiss, Oberkochen, Germany).
Results
In the current case, corneal perforation was observed in
the center of the cornea by slit-lamp examination and a
corneal stromal opacity with fibrosis was seen surround-
ing the perforation area (Figure 1).Figure 3 Double immunostaining for u-PA (green) and u-PAR (red) in
and red channels shown separately. u-PA and u-PAR co-localization were sHE staining of the corneal section of the current case
revealed that both neutrophils and corneal fibroblasts
migrated in the stroma near the corneal ulcer (Figure 2).
Double immunofluorescence was used to detect expres-
sions of u-PA and u-PAR. As shown in Figure 3, u-PA
and u-PAR co-localization was seen in the corneal ulcer-
ation area. Furthermore, double immunostaining results
of u-PA and CD68 or α-SMA showed cells expressing
u-PA were mainly observed in CD68-positive cells
(Figure 4A). Some α-SMA positive cells were also posi-
tive for u-PA (Figure 4B). On the other hand, α2AP was
not expressed in CD68-positive cells (Figure 5A), but was
expressed in α-SMA positive cells (Figure 5B).
Conclusions
The proteolytic activity of plasmin is considered to con-
tribute to tissue remodeling in the wound healing
process [10]. Activation of plasminogen by a plasmino-
gen activator is essential in the initiation of fibrinolysis,corneal tissue near the perforation. A merged image, with green
een in the corneal ulceration area. Magnification ×100.
Figure 4 Expression of u-PA in CD68-positive cells (A) and α-SMA-positive corneal fibroblasts. (B) Double immunostaining for u-PA
(green) and CD68 (red) in corneal tissue near the perforation (A). The arrows indicate that some u-PA-positive cells (green) were also positive for
α-SMA (red; B).
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tissue-type plasminogen activator (t-PA) and u-PA.
u-PA is expressed at the leading edge of the migrating
corneal epithelium, whereas t-PA is expressed at a low
level during corneal epithelial wound healing [11].
In our case, a large number of migrating inflamma-
tory cells and corneal fibroblasts were observed in the
wound edge of the ulcer (Figure 2). This probably indi-
cates repeated and prolonged wound healing reactions.
Steroid eye drops are known to delay wound healing
and are a factor complicating corneal ulceration. In the
present case, long-term steroid treatment may increase
the risk of opportunistic corneal infection and delay
wound healing. As a result, perforation developed in
the central cornea.Figure 5 Expression of α2AP in corneal tissue. No α2AP expression by
contrast, α2AP was expressed in α-SMA-positive cells in the corneal stromaImmunohistochemical examination revealed the expres-
sion of u-PA in concordance with CD68-positive cells
(Figure 4A). At the same time, u-PA was also observed to
be partially expressed in α-SMA positive cells (Figure 4B).
We suggest that u-PA is mainly produced by CD68-
positive cells and also by corneal fibroblasts.
In addition, the expression of u-PAR was observed in
the same cells in which u-PA was expressed (Figure 3).
This clearly indicated that the infiltrating cells were the
u-PA/u-PAR complex. u-PAR expression has been
demonstrated in many cell types including macrophages
and corneal fibroblasts [12,13]; however, the role of
u-PA/u-PAR interaction during ocular inflammation is
not clearly understood. Berstein et al. demonstrated
that non-cleaved u-PAR (D1D2D3) is present in cornealCD68-positive cells in corneal tissue near the perforation (A). In
l opacity area surrounding the perforation (B).
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myofibroblasts [14]. The antibody used in our study was
made for a C-terminal peptide present both on the intact
and cleaved form of the receptor. Therefore, we could
not differentiate whether the molecules that reacted to the
antibody were non-cleaved or cleaved u-PAR (Figure 3).
We hypothesize that u-PAR-bearing cells promote cellular
infiltration into the ulcer by binding u-PA and by local deg-
radation of the peripheral corneal stroma.
On the other hand, although expression of α2AP in
the cornea has been previously reported [15], the func-
tion of α2AP in the cornea has not been elucidated. In
our case, interestingly, α2AP expression was observed
mostly in the corneal stromal opacity area presumably
affected with fibrosis and was barely seen in the ulcer-
ation area. Double staining results revealed that α2AP
was expressed in α-SMA-positive cells and no α2AP
expression was observed in CD68-positive cells
(Figures 5A and B).
Many reports have suggested that activated corneal
fibroblasts produce ECM and are involved in tissue
repair and fibrosis [1,16,17]. The double staining
results could be explained by at least two mechanisms:
(1) α-SMA-positive fibroblasts produce and secrete
α2AP, or (2) α-SMA-positive fibroblasts bind to α2AP.
The concordance between α2AP and α-SMA expression
may indicate that α2AP is somehow functioning with α-
SMA-positive fibroblasts in the fibrotic response.
Kanno et al. [18] demonstrated a new action for α2AP
using α2AP knock-out mice where α2AP was associated
with tissue fibrosis. This may also be the same mechan-
ism in corneal fibrosis.
In the present case, the wound healing process became
prolonged because of the repeated passages of corneal
melting and remodeling at the ulcerated area, eventually
leading to the development of corneal opacity and per-
foration. Further investigations are necessary to elucidate
the role of u-PA, u-PAR and α2AP in corneal ulcers.
These molecules are believed to play a crucial role in in-
flammatory cell recruitment, ECM synthesis and degrad-
ation during corneal wound healing.
To our knowledge, we have identified, for the first
time, the expression of the u-PA/u-PAR complex and
α2AP in a patient with a corneal ulcer.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
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